{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:38:39Z","timestamp":1790627919615,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary artery involvement (PAI) in Takayasu arteritis (TAK) can lead to severe complications, but the relationship between the two has not been fully clarified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively investigated 166 consecutive patients with TAK who attended Kyoto University Hospital from 1997 to 2018. The demographic data, clinical symptoms and signs, comorbidities, treatments, and imaging findings were compared between patients with and without PAI. TAK was diagnosed based on the American College of Rheumatology Classification Criteria (1990) or the Japanese Clinical Diagnostic Criteria (2008). PAI was identified using enhanced computed tomography, magnetic resonance imaging, or lung scintigraphy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PAI was detected in 14.6% (\n                      <jats:italic>n<\/jats:italic>\n                      = 24) of total TAK patients. Dyspnea (25.0% vs. 8.6%;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.043), pulmonary arterial hypertension (PAH) (16.7% vs. 0.0%;\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001), ischemic heart disease (IHD) (29% vs. 9.3%;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.018), respiratory infection (25.0% vs. 6.0%;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.009), and nontuberculous mycobacteria (NTM) infection (20.8% vs. 0.8%;\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) were significantly more frequent, and renal artery stenosis (0% vs. 17%;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.007) was significantly less frequent in TAK patients with PAI than in those without PAI. PAI and biologics were risk factors for NTM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TAK patients with PAI more frequently have dyspnea, PAH, IHD, and respiratory infection, including NTM, than TAK patients without PAI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-021-02675-9","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T23:52:13Z","timestamp":1638489133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The clinical features of pulmonary artery involvement in Takayasu arteritis and its relationship with ischemic heart diseases and infection"],"prefix":"10.1186","volume":"23","author":[{"given":"Hiroki","family":"Mukoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirei","family":"Shirakashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Onizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kitagori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Akizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosaku","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Morinobu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7082-4900","authenticated-orcid":false,"given":"Hajime","family":"Yoshifuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"key":"2675_CR1","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1161\/CIRCULATIONAHA.114.012547","volume":"132","author":"Y Watanabe","year":"2015","unstructured":"Watanabe Y, Miyata T, Tanemoto K. Current clinical features of new patients with Takayasu arteritis observed from cross-country research in Japan: age and sex specificity. Circulation. 2015;132:1701\u20139.","journal-title":"Circulation"},{"key":"2675_CR2","unstructured":"Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, et al. Takayasu\u2019s arteritis in Turkey - clinical and angiographic features of 248 patients. Clin Exp Rheumatol. 2009;27(1 SUPPL. 52)."},{"key":"2675_CR3","doi-asserted-by":"publisher","unstructured":"Lee GY, Jang SY, Ko SM, Kim EK, Lee SH, Han H, et al. Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: Analysis of 204 Korean patients at a single center. Int J Cardiol 2012;159:14\u201320. Available at: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.ijcard.2011.01.094.","DOI":"10.1016\/j.ijcard.2011.01.094"},{"key":"2675_CR4","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3899\/jrheum.140664","volume":"41","author":"L Yang","year":"2014","unstructured":"Yang L, Zhang H, Jiang X, Zou Y, Qin F, Song L, et al. Clinical manifestations and longterm outcome for patients with Takayasu arteritis in China. J Rheumatol. 2014;41:2439\u201346.","journal-title":"J Rheumatol"},{"key":"2675_CR5","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/1756-185X.13354","volume":"21","author":"A Sari","year":"2018","unstructured":"Sari A, Sener YZ, Firat E, Armagan B, Erden A, Oksul M, et al. Pulmonary hypertension in Takayasu arteritis. Int J Rheum Dis. 2018;21:1634\u20139.","journal-title":"Int J Rheum Dis"},{"key":"2675_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5152\/eurjrheum.2018.17052","volume":"5","author":"M Kalfa","year":"2018","unstructured":"Kalfa M, Emmungil H, Musayev O, Soysal Gunduz O, Yilmaz Z, Inal V, et al. Frequency of pulmonary hypertension in transthoracic echocardiography screening is not increased in Takayasu arteritis: Experience from a single center in Turkey. Eur J Rheumatol. 2018;5:249\u201353.","journal-title":"Eur J Rheumatol"},{"key":"2675_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3899\/jrheum.190045","volume":"47","author":"Y He","year":"2020","unstructured":"He Y, Lv N, Dang A, Cheng N. Pulmonary artery involvement in patients with takayasu arteritis. J Rheumatol. 2020;47:264\u201372.","journal-title":"J Rheumatol"},{"key":"2675_CR8","doi-asserted-by":"publisher","unstructured":"Direskeneli H. Pulmonary hypertension in Takayasu\u2019s arteritis: should be monitored closely. Int J Cardiol 2019;276:238\u2013239. Available at: https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.ijcard.2018.10.074.","DOI":"10.1016\/j.ijcard.2018.10.074"},{"key":"2675_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-020-02203-1","volume":"22","author":"X Kong","year":"2020","unstructured":"Kong X, Ma L, Lv P, Cui X, Chen R, Ji Z, et al. Involvement of the pulmonary arteries in patients with Takayasu arteritis: a prospective study from a single centre in China. Arthritis Res Ther. 2020;22:1\u201310.","journal-title":"Arthritis Res Ther"},{"key":"2675_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10067-020-05271-5","volume":"40","author":"X Xi","year":"2021","unstructured":"Xi X, Du J, Liu J, Zhu G, Qi G, Pan L. Pulmonary artery involvement in Takayasu arteritis: a retrospective study in Chinese population. Clin Rheumatol. 2021;40:635\u201344.","journal-title":"Clin Rheumatol"},{"key":"2675_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ijcard.2018.08.047","volume":"276","author":"J Gong","year":"2019","unstructured":"Gong J, Yang Y, Ma Z, Guo X, Wang J, Kuang T, et al. Clinical and imaging manifestations of Takayasu\u2019s arteritis with pulmonary hypertension: a retrospective cohort study in China. Int J Cardiol. 2019;276:224\u20139.","journal-title":"Int J Cardiol"},{"key":"2675_CR12","doi-asserted-by":"crossref","unstructured":"Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33(8):1129\u201334.","DOI":"10.1002\/art.1780330811"},{"key":"2675_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1253\/circj.CJ-88-0007","volume":"75","author":"JCS Guidelines","year":"2011","unstructured":"Guidelines JCS. Guideline for management of vasculitis syndrome (JCS 2008): Digest version. Circ J. 2011;75:474\u2013503.","journal-title":"Circ J"},{"key":"2675_CR14","doi-asserted-by":"publisher","unstructured":"Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019;53. Available at: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1183\/13993003.01913-2018.","DOI":"10.1183\/13993003.01913-2018"},{"key":"2675_CR15","doi-asserted-by":"publisher","unstructured":"Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 1996;54:S155\u2013S163. Available at: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/S0167-5273(96)02813-6.","DOI":"10.1016\/S0167-5273(96)02813-6"},{"key":"2675_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"key":"2675_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016;37:67\u2013119.","journal-title":"Eur Heart J"},{"key":"2675_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3899\/jrheum.140436","volume":"42","author":"X Wang","year":"2015","unstructured":"Wang X, Dang A, Chen B, Lv N, Liu Q. Takayasu arteritis-associated pulmonary hypertension. J Rheumatol. 2015;42:495\u2013503.","journal-title":"J Rheumatol"},{"key":"2675_CR19","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/acr.24055","volume":"72","author":"KB Gribbons","year":"2020","unstructured":"Gribbons KB, Ponte C, Carette S, Craven A, Cuthbertson D, Hoffman GS, et al. Patterns of arterial disease in Takayasu arteritis and giant cell arteritis. Arthritis Care Res. 2020;72:1615\u201324.","journal-title":"Arthritis Care Res"},{"key":"2675_CR20","doi-asserted-by":"publisher","unstructured":"Lee SD, Kim DS, Shim TS, Lim CM, Koh Y, Kim WS, et al. Nitric oxide and molsidomine in the management of pulmonary hypertension in Takayasu\u2019s arteritis. Chest 2001;119:302\u2013307. Available at: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1378\/chest.119.1.302.","DOI":"10.1378\/chest.119.1.302"},{"key":"2675_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1378\/chest.67.1.69","volume":"67","author":"E Lupi","year":"1975","unstructured":"Lupi E, Sanchez G, Horwitz S, Gutierrez E. Pulmonary artery involvement in Takayasu\u2019s arteritis. Chest. 1975;67:69\u201374.","journal-title":"Chest"},{"key":"2675_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2214\/ajr.159.2.1352939","volume":"159","author":"I Yamada","year":"1992","unstructured":"Yamada I, Shibuya H, Matsubara O, Umehara I, Makino T, Numano F, et al. Pulmonary artery disease in Takayasu\u2019s arteritis: angiographic findings. Am J Roentgenol. 1992;159:263\u20139.","journal-title":"Am J Roentgenol"},{"key":"2675_CR23","doi-asserted-by":"crossref","unstructured":"Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77(5):636\u2013643.","DOI":"10.1136\/annrheumdis-2017-212649"},{"key":"2675_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/art.1780350419","volume":"35","author":"K Tanigawa","year":"1992","unstructured":"Tanigawa K, Eguchi K, Kitamura Y, Kawakami A, Ida H, Yamashita S, et al. Magnetic resonance imaging detection of aortic and pulmonary artery wall thickening in the acute stage of Takayasu arteritis. Improvement of clinical and radiologic findings after steroid therapy. Arthritis Rheum. 1992;35:476\u201380.","journal-title":"Arthritis Rheum"},{"key":"2675_CR25","doi-asserted-by":"publisher","unstructured":"Jin SA, Lee JH, Park JH, Oh JK, Kim MS, Park YK, et al. Endovascular treatment in a patient with left main coronary and pulmonary arterial stenoses as an initial manifestation of Takayasu\u2019s arteritis. Hear Lung Circ 2015;24:e26\u2013e30. Available at: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.hlc.2014.09.007.","DOI":"10.1016\/j.hlc.2014.09.007"},{"key":"2675_CR26","doi-asserted-by":"publisher","unstructured":"Kusunose K, Yamada H, Tomita N, Nishio S, Niki T, Yamaguchi K, et al. Serial imaging changes during treatment of Takayasu arteritis with pulmonary artery stenosis. Int J Cardiol 2011;148:e47\u2013e50. Available at: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.ijcard.2009.02.036.","DOI":"10.1016\/j.ijcard.2009.02.036"},{"key":"2675_CR27","first-page":"4","volume":"31","author":"O Addimanda","year":"2013","unstructured":"Addimanda O, Spaggiari L, Pipitone N, Versari A, Pattacini P, Salvarani C. Pulmonary artery involvement in takayasu arteritis. PET\/CT versus CT angiography. Clin Exp Rheumatol. 2013;31:4\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"2675_CR28","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s002590100648","volume":"28","author":"M Castellani","year":"2001","unstructured":"Castellani M, Vanoli M, Cal\u00ec G, Bacchiani G, Origgi L, Reschini E, et al. Ventilation-perfusion lung scan for the detection of pulmonary involvement in Takayasu\u2019s arteritis. Eur J Nucl Med. 2001;28:1801\u20135.","journal-title":"Eur J Nucl Med"},{"key":"2675_CR29","doi-asserted-by":"crossref","unstructured":"Mekinian A, Lambert M, Huglo D, Devos P, Mirault T, Steinling M, et al. Pulmonary perfusion scintigraphy: a tool to detect the presence of pulmonary artery involvement in Takayasu\u2019s arteritis. Press Medicale. 2012;41(2):e37\u201342.","DOI":"10.1016\/j.lpm.2011.09.015"},{"key":"2675_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-018-0755-9","volume":"19","author":"J Yang","year":"2019","unstructured":"Yang J, Peng M, Shi J, Zheng W, Yu X. Pulmonary artery involvement in Takayasu\u2019s arteritis: diagnosis before pulmonary hypertension. BMC Pulm Med. 2019;19:1\u20139.","journal-title":"BMC Pulm Med"},{"key":"2675_CR31","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1253\/circj.CJ-09-0905","volume":"74","author":"AWS de Souza","year":"2010","unstructured":"de Souza AWS, Machado NP, Pereira VM, Arraes AED, Reis Neto ET, Mariz HA, et al. Antiplatelet therapy for the prevention of arterial ischemic events in takayasu arteritis. Circ J. 2010;74:1237\u201341.","journal-title":"Circ J"},{"key":"2675_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/01.CIR.80.3.429","volume":"80","author":"R Subramanyan","year":"1989","unstructured":"Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu\u2019s disease). Circulation. 1989;80:429\u201337.","journal-title":"Circulation"},{"key":"2675_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.31138\/mjr.30.3.171","volume":"30","author":"M Versini","year":"2019","unstructured":"Versini M, Tiosano S, Sharif K, Mahroum N, Watad A, Comaneshter D, et al. Association between Takayasu arteritis and ischemic heart disease: a cohort study. Mediterr J Rheumatol. 2019;30:171.","journal-title":"Mediterr J Rheumatol"},{"key":"2675_CR34","doi-asserted-by":"publisher","unstructured":"Comarmond C, Cluzel P, Toledano D, Costedoat-Chalumeau N, Isnard R, Gaudric J, et al. Findings of cardiac magnetic resonance imaging in asymptomatic myocardial ischemic disease in Takayasu arteritis. Am J Cardiol 2014;113:881\u2013887. Available at: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.amjcard.2013.11.045.","DOI":"10.1016\/j.amjcard.2013.11.045"},{"key":"2675_CR35","doi-asserted-by":"publisher","unstructured":"Park SJ, Kim HJ, Park H, Hann HJ, Kim KH, Han S, et al. Incidence, prevalence, mortality and causes of death in Takayasu arteritis in Korea \u2013 a nationwide, population-based study. Int J Cardiol 2017;235:100\u2013104. Available at: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.ijcard.2017.02.086.","DOI":"10.1016\/j.ijcard.2017.02.086"},{"key":"2675_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.rdc.2013.10.006","volume":"40","author":"E Miloslavsky","year":"2014","unstructured":"Miloslavsky E, Unizony S. The heart in vasculitis. Rheum Dis Clin North Am. 2014;40:11\u201326.","journal-title":"Rheum Dis Clin North Am"},{"key":"2675_CR37","doi-asserted-by":"crossref","unstructured":"Li J, Zhu M, Li M, Zheng W, Zhao J, Tian X, et al. Cause of death in Chinese Takayasu arteritis patients. Medicine (Baltimore). 2016;95(27):e4069.","DOI":"10.1097\/MD.0000000000004069"},{"key":"2675_CR38","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.21037\/jtd-20-267","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang Y, Jia SJ, Zhou Y, Li J, Zhao X, Zhao QM, et al. A study on the risk factors of coronary artery disease in patients with Takayasu arteritis. J Thorac Dis. 2020;12:2031\u20138.","journal-title":"J Thorac Dis"},{"key":"2675_CR39","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s11748-016-0723-3","volume":"65","author":"T Sugiyama","year":"2017","unstructured":"Sugiyama T, Kawaguchi K, Usami N, Yokoi K. Nontuberculous mycobacterial disease concomitant with a pulmonary artery occlusion caused by Takayasu\u2019s arteritis. Gen Thorac Cardiovasc Surg. 2017;65:418\u201321.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2675_CR40","doi-asserted-by":"publisher","unstructured":"Toledano K, Guralnik L, Lorber A, Ofer A, Yigla M, Rozin A, et al. Pulmonary arteries involvement in Takayasu\u2019s arteritis: two cases and literature review. Semin Arthritis Rheum 2011;41:461\u2013470. Available at: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.semarthrit.2011.06.001.","DOI":"10.1016\/j.semarthrit.2011.06.001"},{"key":"2675_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000029490","volume":"67","author":"S Elsasser","year":"2000","unstructured":"Elsasser S, Sol\u00e8r M, Bolliger CT, J\u00e4ger K, Steiger U, Perruchoud AP. Takayasu disease with predominant pulmonary involvement. Respiration. 2000;67:213\u20135.","journal-title":"Respiration"},{"key":"2675_CR42","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/00124743-200210000-00006","volume":"8","author":"NJ Ichi","year":"2002","unstructured":"Ichi NJ, Ito S, Terada M, Saitoh Y, Ichi IK, Nakano M, et al. Pulmonary artery involvement in Takayasu\u2019s arteritis with lung infarction and pulmonary aspergillosis. J Clin Rheumatol. 2002;8:260\u20134 Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/17041382\/. Accessed February 12, 2021.","journal-title":"J Clin Rheumatol"},{"key":"2675_CR43","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2169\/internalmedicine.45.1686","volume":"45","author":"T Nakamura","year":"2006","unstructured":"Nakamura T, Hayashi S, Fukuoka M, Sueoka N, Nagasawa K. Pulmonary infarction as the initial manifestation of Takayasu\u2019s arteritis. Intern Med. 2006;45:725\u20138.","journal-title":"Intern Med"},{"key":"2675_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00408-010-9241-8","volume":"188","author":"TK Marras","year":"2010","unstructured":"Marras TK, Mehta M, Chedore P, May K, Al HM, Jamieson F. Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics. Lung. 2010;188:289\u201399.","journal-title":"Lung"},{"key":"2675_CR45","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.2169\/internalmedicine.53.2558","volume":"53","author":"F Kuroda","year":"2014","unstructured":"Kuroda F, Tanabe N, Igari H, Sakurai T, Sakao S, Tada Y, et al. Nontuberculous mycobacterium diseases and chronic thromboembolic pulmonary hypertension. Intern Med. 2014;53:2273\u20139.","journal-title":"Intern Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02675-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-021-02675-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02675-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T23:52:30Z","timestamp":1638489150000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-021-02675-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2675"],"URL":"https:\/\/doi.org\/10.1186\/s13075-021-02675-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-615708\/v1","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"10 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Kyoto University Graduate School and Faculty of Medicine (G412). All study procedures were performed following the Declaration of Helsinki principles.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HM, MS, NT, TI, TN, HO, HT, KK, SA, RN, KM, and AM claimed no COI for this work. MT has received research grants and\/or speaker fees from AbbVie GK, Asahi Kasei Pharma Corp., Astellas Pharma Inc., Ayumi Pharmaceutical Corp., Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Pfizer Inc., UCB Japan Co., Ltd., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corp., Novartis Pharma K.K., Taisho Pharma Co., Ltd. HY has received lecture fees from Chugai pharmaceuticals and AbbVie, and advisory fees from Janssen pharmaceuticals. Department of Advanced Medicine for Rheumatic Diseases is supported by two local governments in Japan (Nagahama City, Shiga and Toyooka City, Hyogo) and five pharmaceutical companies (Mitsubishi Tanabe Pharma Corp., Chugai Pharmaceutical Co., Ltd., Ayumi Pharmaceutical Corp., Asahi Kasei Pharma Corp. and UCB Japan Co., Ltd.).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"293"}}